XSAT:HAMLET B (Sweden)
Â
Ordinary Shares - Class B
kr
3.91
(+10.14%)
Dec 23
Business Description
Hamlet BioPharma AB publ
ISIN : SE0015661152
Share Class Description:
XSAT:HAMLET B: Ordinary Shares - Class BCompare
Compare
Traded in other countries / regions
HAMLET B.Sweden7ZT.Germany IPO Date
2015-10-23Description
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -40.3 | |||||
| 3-Year EPS without NRI Growth Rate | -49.8 | |||||
| 3-Year FCF Growth Rate | -57.8 | |||||
| 3-Year Book Growth Rate | 145.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.28 | |||||
| 9-Day RSI | 73.58 | |||||
| 14-Day RSI | 66.34 | |||||
| 6-1 Month Momentum % | -41.91 | |||||
| 12-1 Month Momentum % | 86.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.04 | |||||
| Quick Ratio | 4.04 | |||||
| Cash Ratio | 3.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.4 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -72.46 | |||||
| ROA % | -65.65 | |||||
| ROIC % | -93.22 | |||||
| ROC (Joel Greenblatt) % | -7752.55 | |||||
| ROCE % | -71.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.47 | |||||
| Price-to-Tangible-Book | 24.44 | |||||
| EV-to-EBIT | -14.49 | |||||
| EV-to-EBITDA | -19.01 | |||||
| EV-to-FCF | -17.96 | |||||
| Price-to-Net-Current-Asset-Value | 43.44 | |||||
| Price-to-Net-Cash | 55.86 | |||||
| Earnings Yield (Greenblatt) % | -6.9 | |||||
| FCF Yield % | -5.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hamlet BioPharma AB publ Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.273 | ||
| Beta | 0 | ||
| Volatility % | 146.27 | ||
| 14-Day RSI | 66.34 | ||
| 14-Day ATR (kr) | 0.353434 | ||
| 20-Day SMA (kr) | 3.4155 | ||
| 12-1 Month Momentum % | 86.51 | ||
| 52-Week Range (kr) | 1.09 - 5.02 | ||
| Shares Outstanding (Mil) | 167.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hamlet BioPharma AB publ Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hamlet BioPharma AB publ Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hamlet BioPharma AB publ Frequently Asked Questions
What is Hamlet BioPharma AB publ(XSAT:HAMLET B)'s stock price today?
The current price of XSAT:HAMLET B is kr3.91. The 52 week high of XSAT:HAMLET B is kr5.02 and 52 week low is kr1.09.
When is next earnings date of Hamlet BioPharma AB publ(XSAT:HAMLET B)?
The next earnings date of Hamlet BioPharma AB publ(XSAT:HAMLET B) is 2025-02-13.
Does Hamlet BioPharma AB publ(XSAT:HAMLET B) pay dividends? If so, how much?
Hamlet BioPharma AB publ(XSAT:HAMLET B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers